Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles
Journal of Controlled Release · 2024
DOI: 10.1016/j.jconrel.2023.12.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Xiaobei Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, No.266 Fangzheng Avenue, Beibei District, Chongqing 400714, Chi…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is one of the most common primary intracranial tumors in the central nervous system with poor prognosis, high invasiveness, risk of recurrence and low survival rate. Thus, it is urgent and vital to develop drug effective delivery systems that efficiently to traverse the blood-brain barrier and targeted transport therapeutic agents into the GBM tumor site for the treatment of brain tumors. Recently, amphiphilic cucurbit[7]uril-polyethylene glycol-hydrophobic Chlorin e6 (CB[7]-PEG-Ce6) polymer was designed, prepared, and self-assembled into micells (CPC) in an aqueous solution, and chemo drug methyl-triazeno-imidazole-carboxamide (MTIC), loaded into the cavity of CB[7] was subsequently coated with hybrid membrane mUMH (HMC3 membrane: macrophage membrane: U87MG membrane = 1:1:2) to afford mUMH@CPC@MTIC. The surface hybrid membrane mUMH potentially enhance the targeted delivery of CPC@MTIC to GBM tissue. Bioactive MTIC was released from the cavity of CB[7] in response to the high spermine level in GBM tumor microenvironments for effective tumor chemotherapy. The biomimetic mUMH@CPC@MTIC exhibited superior antitumor efficacy against GBM in mice. These findings provide new strategies for the design of biomimetic nanoparticle-based drug delivery systems and promising therapy of GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, No.266 Fangzheng Avenue, Beibei District, Chongqing 400714, China. Electronic address: huangxiaobei@cigit.ac.cn.
- Department of Neurosurgy, Southwest Hospital, Third Military Medical University (Army Medical University), 400038 Chongqing, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, No.266 Fangzheng Avenue, Beibei District, Chongqing 400714, China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400030, Ch…
- Department of Neurosurgy, Southwest Hospital, Third Military Medical University (Army Medical University), 400038 Chongqing, China; Glioma Medical Research Center, Southwest Hospital, Third Military Medical University (…
Förderung
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Huang, X., Mu, N., Ding, Y., Huang, R., Wu, W., Li, L., & Chen, T. (2024). Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.12.033
Vancouver
Huang X, Mu N, Ding Y, Huang R, Wu W, Li L, et al. Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2023.12.033
BibTeX
@article{Huang2024,
author = {Huang, Xiaobei and Mu, Ning and Ding, Yuanfu and Huang, Rong and Wu, Wei and Li, Li and Chen, Tunan},
title = {Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles},
journal = {Journal of Controlled Release},
year = {2024},
doi = {10.1016/j.jconrel.2023.12.033}
}
EUVIMED